ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor ブラジル証券取引所、NASDAQ、NYSE、AMEX、LSEなどの主要取引所からの複数のリアルタイム株価を監視します。

TERN Terns Pharmaceuticals Inc

5.44
0.15 (2.84%)
2024年5月4日 - 終了
15分遅延
名称 銘柄コード 市場 種別
Terns Pharmaceuticals Inc TERN NASDAQ 普通株式
  前日比 前日比 % 現在値 時刻
0.15 2.84% 5.44 07:08:39
始値 安値 高値 終値 前日終値
5.39 5.21 5.57 5.44 5.29
この銘柄の詳細情報 »

最新ニュース

日付 時間 ソース タイトル
2024/5/0405:05GLOBETerns Pharmaceuticals Reports Inducement Grant to New..
2024/4/3005:05GLOBETerns Pharmaceuticals Announces Data from Ongoing Phase 1..
2024/4/1105:05GLOBETerns Pharmaceuticals Appoints Melita Sun Jung as Chief..
2024/3/1505:05GLOBETerns Pharmaceuticals Reports Fourth Quarter and Full Year..
2024/3/1205:05GLOBETerns Pharmaceuticals Announces Orphan Drug Designation..
2024/3/0806:05GLOBETerns Pharmaceuticals Reports Inducement Grant to New..
2024/3/0608:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/2/2806:05GLOBETerns Pharmaceuticals to Participate in Upcoming March..
2024/2/1608:02EDGAR2Form 3 - Initial statement of beneficial ownership of..
2024/2/1422:57EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
2024/2/0806:20EDGAR2Form 8-K - Current report
2024/2/0806:05GLOBETerns Pharmaceuticals Reports Inducement Grants to New Chief..
2024/2/0722:05GLOBETerns Pharmaceuticals Appoints Amy Burroughs as Chief..
2024/2/0306:05GLOBETerns Pharmaceuticals Reports Inducement Grant to New..
2024/1/2609:17EDGAR2Form 4 - Statement of changes in beneficial ownership of..
2024/1/0506:05GLOBETerns Pharmaceuticals to Highlight 2024 Priorities and..
2024/1/0406:05GLOBETerns Pharmaceuticals Reports Inducement Grant to New..
2023/11/3006:05GLOBETerns Pharmaceuticals to Present at the JMP Securities..
2023/11/2806:05GLOBETerns Pharmaceuticals Mourns the Loss of Senthil Sundaram,..
2023/11/1422:05GLOBETerns Pharmaceuticals Reports Third Quarter 2023 Financial..
2023/11/1322:05GLOBETerns Pharmaceuticals Presents Late-Breaking Data from Phase..
2023/11/0922:05GLOBETerns Pharmaceuticals to Participate in Upcoming November..
2023/11/0405:05GLOBETerns Pharmaceuticals Reports Inducement Grants to New..
2023/11/0305:05GLOBETerns Pharmaceuticals Announces First Participant Dosed in..
2023/10/2005:05GLOBETerns Pharmaceuticals to Participate in Upcoming Investor..
2023/10/1621:05GLOBETerns Pharmaceuticals Announces Global Phase 1 Clinical..
2023/10/1105:33EDGAR2Form 8-K - Current report
2023/10/0405:05GLOBETerns Pharmaceuticals Reports Inducement Grants to New..
2023/9/0705:05GLOBETerns Pharmaceuticals Reports Inducement Grants to New..
2023/9/0605:05GLOBETerns Pharmaceuticals to Participate in Upcoming September..
2023/8/0905:53EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/0905:24EDGAR2Form 8-K - Current report
2023/8/0905:15GLOBETerns Pharmaceuticals Reports Second Quarter 2023 Financial..
2023/8/0905:05GLOBETerns Achieves Primary Endpoint and All Secondary Endpoints..
2023/8/0407:00GLOBETerns Pharmaceuticals Reports Inducement Grant to New..
2023/8/0406:22EDGAR2Form 8-K - Current report
2023/8/0406:05GLOBETerns Pharmaceuticals Announces Leadership Transition
2023/7/1905:05GLOBETerns Pharmaceuticals to Host Virtual Key Opinion Leader..
2023/7/0605:05GLOBETerns Pharmaceuticals Reports Inducement Grants to New..
2023/6/2705:05GLOBETerns Pharmaceuticals Highlights New Preclinical Data for..
2023/6/0705:30GLOBETerns Pharmaceuticals to Present at Goldman Sachs 44th..
2023/6/0305:05GLOBETerns Pharmaceuticals Reports Inducement Grants to New..
2023/5/2606:05GLOBETerns Pharmaceuticals Announces Publication of TERN-701..
2023/5/2505:05GLOBETerns Pharmaceuticals to Present at Upcoming Investor..
2023/5/2305:05GLOBETerns Pharmaceuticals to Highlight New Preclinical Data for..
2023/5/1521:05GLOBETerns Pharmaceuticals Reports First Quarter 2023 Financial..
2023/5/1005:05GLOBETerns Pharmaceuticals to Participate in the JMP Securities..

最近閲覧した銘柄

Delayed Upgrade Clock